PD
Prateek Dewan
About Prateek Dewan
Data last updated:
Prateek Dewan is a Whole-Time Director at Medicross Pharma-Chem Limited (since 2023). The company operates in Healthcare. Medicross Pharma-Chem Limited reported revenue of ₹7.48 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 01 Jan 2023 | 1996 | ₹7.48 Cr (FY 2025) | Active |
Board colleagues of Prateek Dewan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anirudh Bhardwaj | 07756888 | Medicross Pharma-Chem Limited | Director |
| Anu Dewan | 07062195 | Medicross Pharma-Chem Limited | Whole-Time Director |
| Arif Masood | 01769260 | Medicross Pharma-Chem Limited | Whole-Time Director |
| Sakshi Bhardwaj | 07756885 | Medicross Pharma-Chem Limited | Director |
| Tariq Masood | 07062236 | Medicross Pharma-Chem Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Prateek Dewan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prateek Dewan
Prateek Dewan currently holds 1 directorship: Medicross Pharma-Chem Limited (Whole-Time Director, since 01 Jan 2023, revenue ₹7.48 Cr (FY 2025)).
Prateek Dewan was first appointed on 01 Jan 2023 as Whole-Time Director at Medicross Pharma-Chem Limited.
The current boards of Prateek Dewan's companies include Anirudh Bhardwaj (Medicross Pharma-Chem Limited), Anu Dewan (Medicross Pharma-Chem Limited), Arif Masood (Medicross Pharma-Chem Limited), Sakshi Bhardwaj (Medicross Pharma-Chem Limited), Tariq Masood (Medicross Pharma-Chem Limited).